Texas Capital Bancshares Inc/Tx (TCBIO) Securities - Tradable (2010 - 2026)

Texas Capital Bancshares (TCBIO) has reported Securities - Tradable for 15 consecutive years, with $3.8 billion the latest figure, recorded in Q2 2026.

• Quarterly Securities - Tradable rose 1.38% year-over-year to $3.8 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $3.8 billion (up 1.38% YoY) and the FY2025 annual result came in at $4.0 billion, up 12.11% from the prior year.
• Securities - Tradable fell to $3.8 billion in Q2 2026 per TCBIO's latest filing, from $3.9 billion in the prior quarter.
• Over the last five years, Securities - Tradable for TCBIO reached as high as $4.0 billion in Q4 2025 and fell as low as $2.4 billion in Q3 2022.
• A 5-year average of $3.3 billion and a median of $3.5 billion in 2024 frame the typical range for Securities - Tradable.
• Annual changes were most pronounced in 2022 — Securities - Tradable decreased 26.07% — and 2023, when it jumped 32.22%.
• Year by year, Securities - Tradable stood at $2.6 billion in 2022, then advanced by 23.33% to $3.2 billion in 2023, then rose by 9.26% to $3.5 billion in 2024, then gained by 12.11% to $4.0 billion in 2025, then slipped by 3.17% to $3.8 billion in 2026.
• According to Business Quant data, Securities - Tradable over the past three periods registered $3.8 billion, $3.9 billion, and $4.0 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.